BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ICVS - ECPv6.15.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ICVS
X-ORIGINAL-URL:https://icvs.uminho.pt
X-WR-CALDESC:Events for ICVS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20251204T130000
DTEND;TZID=UTC:20251204T140000
DTSTAMP:20260430T153128
CREATED:20251127T150837Z
LAST-MODIFIED:20251127T151146Z
UID:14429-1764853200-1764856800@icvs.uminho.pt
SUMMARY:ICVS Advanced Seminar "NDR1/2 Kinases in Retinal Neurodegeneration: How NDR2 Shapes Microglial Activation and Neurovascular Dysfunction in Diabetes"
DESCRIPTION:December 4th at 1 pm\, don’t miss Hélène Léger‘s “NDR1/2 Kinases in Retinal Neurodegeneration: How NDR2 Shapes Microglial Activation and Neurovascular Dysfunction in Diabetes” at the A0.03 auditorium in UMinho’s School of Medicine. \nDr. Hélène Léger is a Junior Researcher in the Retinal Dysfunction & Neuroinflammation Lab at the Coimbra Institute for Clinical and Biomedical Research (iCBR)\, Faculty of Medicine\, University of Coimbra. Her research focuses on how Hippo pathway kinases—particularly NDR1 and NDR2—regulate retinal inflammation\, vascular function\, and neurodegeneration. In this seminar\, she will discuss how NDR2 orchestrates microglial activation and microglia–endothelial communication in the context of diabetic retinopathy.
URL:https://icvs.uminho.pt/event/icvs-advanced-seminar-ndr1-2-kinases-in-retinal-neurodegeneration-how-ndr2-shapes-microglial-activation-and-neurovascular-dysfunction-in-diabetes/
ATTACH;FMTTYPE=image/png:https://icvs.uminho.pt/wp-content/uploads/2025/11/event_site_icvs_seminar_helene.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251211T130000
DTEND;TZID=UTC:20251211T140000
DTSTAMP:20260430T153128
CREATED:20251127T151056Z
LAST-MODIFIED:20251210T135807Z
UID:14432-1765458000-1765461600@icvs.uminho.pt
SUMMARY:ICVS Advanced Seminar "The Proteostasis Code of the iMSCs Secretome in Parkinson’s Disease"
DESCRIPTION:December 11th at 1 pm\, don’t miss Belém Sampaio Marques´’s “”The Proteostasis Code of the iMSCs Secretome in Parkinson’s Disease”” at the A0.02 auditorium in UMinho’s School of Medicine. \nBelém Sampaio Marques is a Junior Researcher at ICVS and an Invited Assistant Professor at the University of Minho’s School of Medicine. She holds a Ph.D. in Health Sciences from the University of Minho and specializes in aging and age-related diseases\, particularly neurodegenerative diseases such as Parkinson’s. Her research focuses on Parkinson’s disease and the potential of mesenchymal stem cell (MSCs) secretome in neuroprotection and repair.
URL:https://icvs.uminho.pt/event/icvs-advanced-seminar-the-proteostasis-code-of-the-imscs-secretome-in-parkinsons-disease/
ATTACH;FMTTYPE=image/png:https://icvs.uminho.pt/wp-content/uploads/2025/11/event_site_icvs_seminar_belem.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251215T130000
DTEND;TZID=UTC:20251215T140000
DTSTAMP:20260430T153128
CREATED:20251127T150535Z
LAST-MODIFIED:20251127T150535Z
UID:14426-1765803600-1765807200@icvs.uminho.pt
SUMMARY:ICVS Student Seminar “Novel KDM4C inhibitors for the treatment of Triple Negative Breast Cancer: rational design\, synthesis and biological validation”
DESCRIPTION:December 15th at 1 pm\, don’t miss Sofia Sousa‘s “Novel KDM4C inhibitors for the treatment of Triple Negative Breast Cancer: rational design\, synthesis and biological validation” at the A0.02 auditorium in UMinho’s School of Medicine.
URL:https://icvs.uminho.pt/event/icvs-student-seminar-novel-kdm4c-inhibitors-for-the-treatment-of-triple-negative-breast-cancer-rational-design-synthesis-and-biological-validation/
ATTACH;FMTTYPE=image/png:https://icvs.uminho.pt/wp-content/uploads/2025/11/event_seminar_sofia_sousa.png
END:VEVENT
END:VCALENDAR